News und Analysen
EQS-News: GSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis
EQS-News: GSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis
EQS-News: CECONOMY AG: FY 2021/22 - Sales above previous year, adjusted EBIT in the upper range of the guidance
EQS-News: CECONOMY AG: FY 2021/22 - Sales above previous year, adjusted EBIT in the upper range of the guidance
EQS-News: GRENKE AG: New investment grade rating – Fitch rating 'BBB' with stable outlook
EQS-News: GRENKE AG: New investment grade rating – Fitch rating 'BBB' with stable outlook
EQS-News: MorphoSys Reports Preliminary Q3 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
EQS-News: MorphoSys Reports Preliminary Q3 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
EQS-Adhoc: Krones AG: Krones raises guidance for revenue growth in 2022
EQS-Adhoc: Krones AG: Krones raises guidance for revenue growth in 2022
EQS-Adhoc: Nagarro SE: Further increase in guidance for FY 2022
EQS-Adhoc: Nagarro SE: Further increase in guidance for FY 2022
EQS-News: AUTO1 Group SE: AUTO1 Group sells 163,500 units in Q3 2022
EQS-News: AUTO1 Group SE: AUTO1 Group sells 163,500 units in Q3 2022
EQS-News: SHOP APOTHEKE EUROPE: STRONG OPERATIONAL PERFORMANCE, GROWING FAST AND IMPROVING THE BOTTOM LINE.
EQS-News: SHOP APOTHEKE EUROPE: STRONG OPERATIONAL PERFORMANCE, GROWING FAST AND IMPROVING THE BOTTOM LINE.
EQS-Adhoc: GRENKE AG: GRENKE raises forecast for new leasing business for the 2022 financial year
EQS-Adhoc: GRENKE AG: GRENKE raises forecast for new leasing business for the 2022 financial year
EQS-News: SHOP APOTHEKE EUROPE presents its NET ZERO Strategy 2040 at this year's Retail Media Summit.
EQS-News: SHOP APOTHEKE EUROPE presents its NET ZERO Strategy 2040 at this year's Retail Media Summit.
EQS-Adhoc: 1&1 Forecast 2022: Revenue target confirmed, earnings increased. Capex needs and customer growth lower.
EQS-Adhoc: 1&1 Forecast 2022: Revenue target confirmed, earnings increased. Capex needs and customer growth lower.
EQS-News: Nagarro Announces Resignation of Vice-Chairperson Detlef Dinsel from Supervisory Board
EQS-News: Nagarro Announces Resignation of Vice-Chairperson Detlef Dinsel from Supervisory Board
EQS-News: MorphoSys Presents New Long-Term Data from L-MIND Suggesting Durable Response to Treatment with Monjuvi® (tafasitamab-cxix) for Patients with R/R DLBCL
EQS-News: MorphoSys Presents New Long-Term Data from L-MIND Suggesting Durable Response to Treatment with Monjuvi® (tafasitamab-cxix) for Patients with R/R DLBCL
EQS-News: Nagarro refinances its syndicated loan facility
EQS-News: Nagarro refinances its syndicated loan facility
EQS-Adhoc: Nagarro SE: Management Board of Nagarro SE resolves on share buyback program with a volume of up to 10 million Euro
EQS-Adhoc: Nagarro SE: Management Board of Nagarro SE resolves on share buyback program with a volume of up to 10 million Euro
EQS-News: Schaeffler AG: From e-motors to fuel cell drives: Schaeffler innovations premiere at IAA Transportation
EQS-News: Schaeffler AG: From e-motors to fuel cell drives: Schaeffler innovations premiere at IAA Transportation
DGAP-News: 1&1 mobile network: Unexpected delay at first stopover due to supply bottlenecks
DGAP-News: 1&1 mobile network: Unexpected delay at first stopover due to supply bottlenecks
DGAP-News: SHOP APOTHEKE EUROPE READY FOR THE NEXT PHASE OF E-PRESCRIPTIONS IN GERMANY.
DGAP-News: SHOP APOTHEKE EUROPE READY FOR THE NEXT PHASE OF E-PRESCRIPTIONS IN GERMANY.
DGAP-News: MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters
DGAP-News: MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters
DGAP-News: Nagarro SE posts 65.0% YoY revenue growth in Q2
DGAP-News: Nagarro SE posts 65.0% YoY revenue growth in Q2
DGAP-News: PATRIZIA SE: PATRIZIA delivers robust performance in uncertain market environment
DGAP-News: PATRIZIA SE: PATRIZIA delivers robust performance in uncertain market environment
DGAP-News: CANCOM: Group revenue in the second quarter at the prior year's level. Noticeable improvements visible since June.
DGAP-News: CANCOM: Group revenue in the second quarter at the prior year's level. Noticeable improvements visible since June.
DGAP-News: GRENKE AG: GRENKE increases Consolidated Group net profit again in the second quarter of 2022
DGAP-News: GRENKE AG: GRENKE increases Consolidated Group net profit again in the second quarter of 2022
DGAP-News: AUTO1 Group SE: Autohero secures in-house production capacity of up to 18,500 cars in Belgium
DGAP-News: AUTO1 Group SE: Autohero secures in-house production capacity of up to 18,500 cars in Belgium